More on this book
Community
Kindle Notes & Highlights
Started reading
July 24, 2022
It was within a year of the vaccination campaign, however, that researchers noticed something rather unusual. Several cases of narcolepsy appeared to be related to one of the H1N1 vaccines used in Europe, called Pandemrix. The numbers of cases of narcolepsy rose dramatically in countries where this vaccine was used, particularly in children, but a similar increase in numbers was not seen in the USA, which used a different vaccine. In later years, the numbers of new cases dropped down to levels prior to this vaccination programme. It was not only the vaccination that was associated with onset
...more
Subsequent studies, including our own, have demonstrated this strong association between Pandemrix and narcolepsy. The vaccine has been associated with a two-to twentyfold increased risk of developing narcolepsy. But this marked increase in cases has not been seen with the other commonly used H1N1 vaccine. The reason for this is not entirely understood, although there are subtle differences between the two vaccines, in the nature and quantities of the viral fragments contained. Studies have shown that the chemical structure of fragments of the H1N1 virus are very similar to bits of the
...more
This concept of collateral damage of the immune system is not a new one in the world of neurology. There are many neurological conditions that have a similar basis. Guillain—Barré syndrome, a devastating and life-threatening destruction of peripheral nerves, has long been known to be triggered by Campylobacter, a bacterium that causes food poisoning, and post-infection and post-vaccination damage to the brain or peripheral nerves is well recognised. Infectious agents will often use ‘molecular mimicry’ — appearing structurally similar to the body’s own molecules — to outsmart the immune system.
...more
This highlight has been truncated due to consecutive passage length restrictions.

